{"title":"在接受直接经皮冠状动脉治疗的STE-ACS患者中揭示吸烟悖论的现实","authors":"M. Siddiqui, Rajesh Kumar, J. Sial, M. Karim","doi":"10.47144/phj.v55isupplement1.2418","DOIUrl":null,"url":null,"abstract":"Objectives: Main objective for this study to unfold this controversy in South Asian population in terms of clinical, angiographic parameters and its in-hospital outcomes. \nMethodology: In this study, we included 1756 consecutive patients diagnosed with STEMI undergoing primary PCI. Patients were classified into smokers and nonsmokers. Comparison was done on the basis of baseline characteristics, clinical presentation, angiographic features and in-hospital mortality between two groups. Multivariable logistic regression analysis was performed to evaluate the paradoxical role of smoking. \nResults: Smokers were younger (53.78±11.16 years vs. 56.43±11.17 years; p<0.001) and more frequently male (98.7% vs. 69.9%; p<0.001), and had less diabetes (19.6% vs. 44.8%; p<0.001) and hypertension (38.5% vs. 64.9%; p<0.001). Smokers presented less frequently in Killip III (5.6% vs. 8.1%; p<0.001) and Killip IV (2.5% vs. 4.8%; p<0.001) in smokers group. Smokers mostly had single vessel disease (41.7% vs. 34.4%; p=0.013) whereas non-smokers had complex disease and frequently presented with total occlusion of the culprit vessel (64.6% vs. 58.8%; p=0.040). Complication such as slow flow/no-flow (24.3% vs. 33.2%; p<0.001) and cardiogenic shock (2.3% vs. 4.6%; p<0.001) were also seen less often among smokers. Smokers has significantly lesser mortality (1.8% vs. 4.3%; p=0.009) compared to non-smokers with an odds ratio (OR) of 0.41 [95% CI: 0.21-0.82, p=0.011], however, adjusted OR on multivariable analysis was 0.67 [95% CI: 0.31-1.41, p=0.290]. Independent predictors of mortality were found to be history of CVA/stroke, pre-procedure LVEDP, multi-vessel diseases, and RBS in ER adjusted OR of 3.83 [95% CI: 1.24-11.79; p=0.019], 1.07 [95% CI: 1.03-1.12; p=0.002], 2.2 [95% CI: 1.07-4.54; p=0.033], and 1 [95% CI: 1.0-1.01; p=0.032], respectively. \nConclusion: The controversial phenomenon of smoking paradox seems to be unfolded in South Asian population in post STE-ACS patients. The paradoxical protective role of smoking is confounding effect of mainly younger age, less coronary artery disease burden and complexity, lower prevalence of diabetes and hypertension and lower rate of Killip III/IV at presentation. Hence, the protective effect is insignificant in multivariable analysis and history of CVA/stroke, pre-procedure LVEDP, multi-vessel diseases, and RBS in ER were found to be independent predictors of in-hospital mortality.","PeriodicalId":42273,"journal":{"name":"Pakistan Heart Journal","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"UNFOLDING THE REALITY OF SMOKING PARADOX IN PATIENTS PRESENTING WITH STE-ACS UNDERGOING PRIMARY PERCUTANEOUS CORONARY TREATMENT\",\"authors\":\"M. Siddiqui, Rajesh Kumar, J. Sial, M. Karim\",\"doi\":\"10.47144/phj.v55isupplement1.2418\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objectives: Main objective for this study to unfold this controversy in South Asian population in terms of clinical, angiographic parameters and its in-hospital outcomes. \\nMethodology: In this study, we included 1756 consecutive patients diagnosed with STEMI undergoing primary PCI. Patients were classified into smokers and nonsmokers. Comparison was done on the basis of baseline characteristics, clinical presentation, angiographic features and in-hospital mortality between two groups. Multivariable logistic regression analysis was performed to evaluate the paradoxical role of smoking. \\nResults: Smokers were younger (53.78±11.16 years vs. 56.43±11.17 years; p<0.001) and more frequently male (98.7% vs. 69.9%; p<0.001), and had less diabetes (19.6% vs. 44.8%; p<0.001) and hypertension (38.5% vs. 64.9%; p<0.001). Smokers presented less frequently in Killip III (5.6% vs. 8.1%; p<0.001) and Killip IV (2.5% vs. 4.8%; p<0.001) in smokers group. Smokers mostly had single vessel disease (41.7% vs. 34.4%; p=0.013) whereas non-smokers had complex disease and frequently presented with total occlusion of the culprit vessel (64.6% vs. 58.8%; p=0.040). Complication such as slow flow/no-flow (24.3% vs. 33.2%; p<0.001) and cardiogenic shock (2.3% vs. 4.6%; p<0.001) were also seen less often among smokers. Smokers has significantly lesser mortality (1.8% vs. 4.3%; p=0.009) compared to non-smokers with an odds ratio (OR) of 0.41 [95% CI: 0.21-0.82, p=0.011], however, adjusted OR on multivariable analysis was 0.67 [95% CI: 0.31-1.41, p=0.290]. Independent predictors of mortality were found to be history of CVA/stroke, pre-procedure LVEDP, multi-vessel diseases, and RBS in ER adjusted OR of 3.83 [95% CI: 1.24-11.79; p=0.019], 1.07 [95% CI: 1.03-1.12; p=0.002], 2.2 [95% CI: 1.07-4.54; p=0.033], and 1 [95% CI: 1.0-1.01; p=0.032], respectively. \\nConclusion: The controversial phenomenon of smoking paradox seems to be unfolded in South Asian population in post STE-ACS patients. The paradoxical protective role of smoking is confounding effect of mainly younger age, less coronary artery disease burden and complexity, lower prevalence of diabetes and hypertension and lower rate of Killip III/IV at presentation. Hence, the protective effect is insignificant in multivariable analysis and history of CVA/stroke, pre-procedure LVEDP, multi-vessel diseases, and RBS in ER were found to be independent predictors of in-hospital mortality.\",\"PeriodicalId\":42273,\"journal\":{\"name\":\"Pakistan Heart Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-11-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pakistan Heart Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47144/phj.v55isupplement1.2418\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47144/phj.v55isupplement1.2418","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
目的:本研究的主要目的是揭示南亚人群在临床、血管造影参数及其住院结果方面的争议。方法:在这项研究中,我们纳入了1756例连续诊断为STEMI并接受初级PCI治疗的患者。患者分为吸烟者和非吸烟者。比较两组患者的基线特征、临床表现、血管造影特征和住院死亡率。采用多变量logistic回归分析来评估吸烟的矛盾作用。结果:吸烟者年龄较轻(53.78±11.16岁∶56.43±11.17岁);P <0.001),男性更常见(98.7%比69.9%;P <0.001),糖尿病患者较少(19.6% vs. 44.8%;P <0.001)和高血压(38.5% vs. 64.9%;p < 0.001)。Killip III期吸烟者出现的频率较低(5.6%比8.1%;p<0.001)和Killip IV (2.5% vs. 4.8%;P <0.001)。吸烟者多为单血管疾病(41.7% vs. 34.4%;P =0.013),而非吸烟者有复杂的疾病,经常表现为罪魁祸首血管完全闭塞(64.6% vs. 58.8%;p = 0.040)。并发症如慢流/无流(24.3% vs. 33.2%;P <0.001)和心源性休克(2.3% vs. 4.6%;P <0.001)在吸烟者中也较少见。吸烟者的死亡率明显较低(1.8% vs. 4.3%;p=0.009)与非吸烟者相比,优势比(OR)为0.41 [95% CI: 0.21-0.82, p=0.011],然而,多变量分析调整后的OR为0.67 [95% CI: 0.31-1.41, p=0.290]。CVA/卒中史、术前LVEDP、多血管疾病和RBS是死亡率的独立预测因素,经ER调整的OR为3.83 [95% CI: 1.24-11.79;p=0.019], 1.07 [95% CI: 1.03-1.12;p=0.002], 2.2 [95% CI: 1.07-4.54;p=0.033], 1 [95% CI: 1.0-1.01;分别p = 0.032)。结论:有争议的吸烟悖论现象似乎在南亚人群的STE-ACS后患者中展开。吸烟的矛盾保护作用主要是年轻、冠状动脉疾病负担和复杂性较低、糖尿病和高血压患病率较低以及发病时Killip III/IV率较低的混淆效应。因此,在多变量分析中,CVA/卒中史、术前LVEDP、多血管疾病和ER中的RBS是院内死亡率的独立预测因子,其保护作用不显著。
UNFOLDING THE REALITY OF SMOKING PARADOX IN PATIENTS PRESENTING WITH STE-ACS UNDERGOING PRIMARY PERCUTANEOUS CORONARY TREATMENT
Objectives: Main objective for this study to unfold this controversy in South Asian population in terms of clinical, angiographic parameters and its in-hospital outcomes.
Methodology: In this study, we included 1756 consecutive patients diagnosed with STEMI undergoing primary PCI. Patients were classified into smokers and nonsmokers. Comparison was done on the basis of baseline characteristics, clinical presentation, angiographic features and in-hospital mortality between two groups. Multivariable logistic regression analysis was performed to evaluate the paradoxical role of smoking.
Results: Smokers were younger (53.78±11.16 years vs. 56.43±11.17 years; p<0.001) and more frequently male (98.7% vs. 69.9%; p<0.001), and had less diabetes (19.6% vs. 44.8%; p<0.001) and hypertension (38.5% vs. 64.9%; p<0.001). Smokers presented less frequently in Killip III (5.6% vs. 8.1%; p<0.001) and Killip IV (2.5% vs. 4.8%; p<0.001) in smokers group. Smokers mostly had single vessel disease (41.7% vs. 34.4%; p=0.013) whereas non-smokers had complex disease and frequently presented with total occlusion of the culprit vessel (64.6% vs. 58.8%; p=0.040). Complication such as slow flow/no-flow (24.3% vs. 33.2%; p<0.001) and cardiogenic shock (2.3% vs. 4.6%; p<0.001) were also seen less often among smokers. Smokers has significantly lesser mortality (1.8% vs. 4.3%; p=0.009) compared to non-smokers with an odds ratio (OR) of 0.41 [95% CI: 0.21-0.82, p=0.011], however, adjusted OR on multivariable analysis was 0.67 [95% CI: 0.31-1.41, p=0.290]. Independent predictors of mortality were found to be history of CVA/stroke, pre-procedure LVEDP, multi-vessel diseases, and RBS in ER adjusted OR of 3.83 [95% CI: 1.24-11.79; p=0.019], 1.07 [95% CI: 1.03-1.12; p=0.002], 2.2 [95% CI: 1.07-4.54; p=0.033], and 1 [95% CI: 1.0-1.01; p=0.032], respectively.
Conclusion: The controversial phenomenon of smoking paradox seems to be unfolded in South Asian population in post STE-ACS patients. The paradoxical protective role of smoking is confounding effect of mainly younger age, less coronary artery disease burden and complexity, lower prevalence of diabetes and hypertension and lower rate of Killip III/IV at presentation. Hence, the protective effect is insignificant in multivariable analysis and history of CVA/stroke, pre-procedure LVEDP, multi-vessel diseases, and RBS in ER were found to be independent predictors of in-hospital mortality.